Yiming Zhao, Longrong Wang, Anrong Mao, Weiping Zhu, Ti Zhang, Qi Pan, Lu Wang. "Tislelizumab combined with donafenib and GEMOX as first-line treatment for advanced biliary tract cancer: A single-arm, phase II study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4110